Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952405 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fumarylacetoacetate Hydrolase (Fumarylacetoacetase) (FAH) (AA 14-41), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity Chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 14-41, N-Term
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Human variation in alcohol response is influenced by variation in neuronal signaling genes.
Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA.
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.
Tyrosinaemia type I--de novo mutation in liver tissue suppressing an inborn splicing defect.
Joslyn G, Ravindranathan A, Brush G, Schuckit M, White RL
Alcoholism, clinical and experimental research 2010 May;34(5):800-12
Alcoholism, clinical and experimental research 2010 May;34(5):800-12
Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA.
Liu J, Pearlson G, Windemuth A, Ruano G, Perrone-Bizzozero NI, Calhoun V
Human brain mapping 2009 Jan;30(1):241-55
Human brain mapping 2009 Jan;30(1):241-55
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.
Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ, MacLean AW, St CD, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH, Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood DH, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N, Wellcome Trust Case Control Consortium.
Nature genetics 2008 Sep;40(9):1056-8
Nature genetics 2008 Sep;40(9):1056-8
Tyrosinaemia type I--de novo mutation in liver tissue suppressing an inborn splicing defect.
Bliksrud YT, Brodtkorb E, Andresen PA, van den Berg IE, Kvittingen EA
Journal of molecular medicine (Berlin, Germany) 2005 May;83(5):406-10
Journal of molecular medicine (Berlin, Germany) 2005 May;83(5):406-10
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Confocal immunofluorescent analysis of Fumarylacetoacetase Antibody (N-term) Cat.-No AP51509PU-N with HepG2 cell followed by Alexa Fluor 488-conjugated goat anti-rabbit lgG (green). DAPI was used to stain the cell nuclear (blue).
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
